References
- Ali Y, Lehmussaari K. Industrial perspective in ocular drug delivery. Adv Drug Deliv Rev 2006; 58: 1258–68
- Al-Kassas R. Design and in vitro evaluation of gentamicin-Eudragit microspheres intended for intra-ocular administration. J Microencapsul 2004; 21(1)71–81
- Bourlais CL, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems—Recent advances. Prog Retin Eye Res 1998; 17(1)33–58
- Das S, Suresh PK, Desmukh R. Design of Eudragit RL100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomedicine 2010; 6(2)318–23
- Dillen K, Vandervoort J, Van den Mooter G, Ludwig A. Evaluation of ciprofloxacin-loaded Eudragit® RS100 or RL100/PLGA nanoparticles. Int J Pharm 2006; 314(1)72–82
- Gaudana R, Jwala J, Boddu SH, Mitra AK. Recent perspectives in ocular drug delivery. Pharm Res 2009; 26(5)1197–216
- Haznedar S, Dortunc B. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Int J Pharm 2004; 269(1)131–40
- Joshi A. Microparticulates for ophthalmic drug delivery. J Ocul Pharmacol 1994; 10(1)29–45
- Kachrimanis K, Nikolakakis I, Malamataris S. Spherical crystal agglomeration of ibuprofen by the solvent-change technique in presence of methacrylic polymers. J Pharm Sci 2000; 89(2)250–9
- Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 2005; 57: 1595–639
- Maghsoodi M. Physicomechanical properties of naproxen-loaded microparticles prepared from Eudragit L100. AAPS PharmSciTech 2009; 10(1)120–8
- Mateović-Rojnik T, Frlan R, Bogataj M, Bukovec P, Mrhar A. Effect of preparation temperature in solvent evaporation process on Eudragit RS microsphere properties. Chem Pharm Bull 2005; 53(1)143–6
- McGinity JW, O’Donnell PB. Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliv Rev 1997; 28(1)25–42
- Minami K, Kamei C. A chronic model for evaluating the itching associated with allergic conjunctivitis in rats. Int Immunopharmacol 2004; 4(1)101–8
- Pignatello R, Bucolo C, Ferrara P, Maltese A, Puleo A, Puglisi G. Eudrgit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Euro J Pharm Sci 2002; 16(1–2)53–61
- Pignatello R, Ricupero N, Bucolo C, Maugeri F, Maltese A, Puglisi G. Preparation and characterization of Eudragit retard nanosuspensions for the ocular delivery of cloricromene. AAPS PharmSciTech 2006; 7(1)E27
- Rosca ID, Watari F, Uo M. Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J Control Release 2004; 99(2)271–80
- Stern ME, Siemasko K, Gao J, Duong A, Beauregard C, Calder V, Niederkorn JY. Role of interferon-gamma in a mouse model of allergic conjunctivitis. Invest Ophthalmol Vis Sci 2005; 46(9)3239–46
- Ubrich N, Schmidt C, Bodmeier R, Hoffman M, Maincent P. Oral evaluation in rabbits of cyclosporine-loaded Eudragit RS or RL nanoparticles. Int J Pharm 2005; 288(1)169–75
- Vasir JK, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm 2003; 255: 13–32
- Zimmer A, Kreuter J. Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev 1995; 16: 61–73